BOARD OF DIRECTORS
The Company’s policy towards the composition of the Board is to have an appropriate mix of Executive and Non- executive & Independent & women Directors to maintain the independence of the Board and to separate its functions of governance and management. The Company is having Four Non-Executive Directors out of which three are Independent in terms of Section 149 of the Companies Act, 2013, more than half of the total number of directors on the Board are Independent for providing better means to Corporate Governance norms as envisaged in Clause 49 of the Listing Agreement.
None of the Directors on the Board is a member of more than 10 Committees and Chairman of more than 5 Committees as specified in Clause 49 of the Listing Agreement, across all the companies in which he/she is a director. The Directors have made the necessary disclosures regarding Committee positions.
The functions, responsibility, role and accountability of the Board are well defined. The detailed reports of the company activities and performances are periodically placed before the Board for effective decision-making.
|Present Structure of the Board|
|Name of the Director||Category|
|Shri Gopal Sitaram Jiwarajka||Chairman & Managing Director|
|Shri Gautam Khaitan||Non-Executive Independent Director|
|Shri Patanjali Govind Keswani||Non-Executive Independent Director|
|Smt. Sushmita Shekhar||Non-Executive Independent Director|
|Shri Sanjeev Kaul Duggal||Non-Executive Independent Director|
|Shri Prem Nath Mehta||Non-Executive Director|
|Shri Tarun Jiwarajka||Whole Time Director|
Board and its committee Meetings and procedures
All material information is circulated to the Directors before the meeting or placed at the meeting, including information required to be made available to the Board under Clause 49 of the Listing Agreement with Stock Exchanges. The Company has established the procedures to enable the Board to periodically review compliance report of laws applicable to the Company.
SALORA INTERNATIONAL LTD
D-13/4, Okhla Industrial Area, Phase-ii,
New Delhi-110020, Delhi, India